T-cell receptors (TCRs) play a central role in the immune system. TCRs on T-cell surfaces can specifically recognize peptide antigens presented by antigen presenting cells (APCs)
It is convenient to study TCRs in mouse models, which can be accomplished in several ways. Making TCR transgenic mouse models is costly and time-consuming and currently there are only a limited number of them available [2] [3] [4] . Alternatively, mice with antigen-specific T-cells can be generated by bone marrow chimera. This method also takes several weeks and requires expertise 5 . Retroviral transduction of TCRs into in vitro activated mouse T-cells is a quick and relatively easy method to obtain T-cells of desired peptide-MHC specificity. Antigen-specific T-cells can be generated in one week and used in any downstream applications. Studying transduced T-cells also has direct application to human immunotherapy, as adoptive transfer of human T-cells transduced with antigen-specific TCRs is an emerging strategy for cancer treatment 6 .
Here we present a protocol to retrovirally transduce TCRs into in vitro activated mouse T-cells. Both human and mouse TCR genes can be used. Retroviruses carrying specific TCR genes are generated and used to infect mouse T-cells activated with anti-CD3 and anti-CD28 antibodies. After in vitro expansion, transduced T-cells are analyzed by flow cytometry.
Video Link
The video component of this article can be found at http://www.jove.com/video/2307/ Protocol 1. Prepare Retroviral Construct 1. Sub-clone the T-cell receptor (TCR) gene of interest into a retroviral vector (Figure 1 , example vectors pMSG 7 , pMIGII 5, 8 , pMXs from Cellbiolabs). The TCR α and β chain gene should be on the same vector under the control of the same promoter to ensure equal expression. If the TCR of interest is human, the human constant domains need to be replaced by mouse constant domains 9 . Our observation is that full length human TCRs do not stably express on mouse T-cells. 2. Prepare high quality plasmid DNA using Qiagen Maxi Prep Kit or similar product. The concentration of the plasmid should be at around 1 μg/ μL. Slowly drip the mixture (total 3 mL) into the Plat-E cells. Gently rock the plate back and forth to distribute the transfection mixture evenly. 8. Incubate cells at 37 °C/5% CO 2 in a cell incubator. 9. After 6-8 hours, replace medium with 10 mL of fresh DMEM medium (with Pen/Strep) for viral production. 21. Just before adding the cells, remove antibody solution from the plate (prepared previously in 2.11). Rinse each well with sterile PBS and remove PBS. 22. Add 1 mL of the cell suspension to each well. Put the plate at 37°C/5% CO 2 in a cell incubator.
(Day 2 and Day 3) Infection of Activated T-cells
1. After 2 days of virus production, the medium in the Plat-E cell plate should become yellow. Transfer viral supernatant to a 15 mL conical tube.
Add 10 mL of fresh DMEM medium to the plate for further viral production (Optional). 
Representative Results
It is often advantageous to purify T-cell subsets before transduction although splenocytes can be transduced without purification. High purity Tcell subsets can be obtained using commercial magnetic beads (Figure 2a ).
To evaluate the expression level of TCRs on T-cells, antibodies specific for TCR alpha or beta chains can be used. Typically 30% to 80% of the cells can express transduced TCR (Figure 2b ) depending on the TCR genes and virus titers. MHC tetramer specific for the TCR can also be used to further verify functional expression of TCRs (Figure 2c ). 
Discussion
Several steps are critical to achieve optimal results. Plat-E packaging cell line should be kept in healthy condition. If necessary, the cells can be passaged a few times in DMEM medium with 1 μg/mL puromycin, 10 μg/ml blasticidin to prevent loss of retroviral structure protein expression. On the day of transfection, the cells should be ~80% confluent. Too few or too many cells may reduce the virus titer. The virus quality can be checked by testing on cell lines that can be easily transduced. Since TCRs require CD3 complexes to be expressed on the cell surface, we routinely use 58α-/β-hybridoma cells 10 (a cell line that does not express endogenous TCR α or β chain, but does express CD3 complex). We obtain nearly 100% transduction efficiency of hybridoma cells when transducing cells with 1 mL of virus supernatant. Finally, the T-cells need to be activated and proliferating because retrovirus can only infect actively dividing cells.
The method presented here for producing antigen-specific T-cells has several limitations. First, it is difficult to reach 100% transduction efficiency for primary mouse T-cells. A portion of the cells do not express the TCR of interest. Second, the transduced TCR α and β chains can mispair with endogenous TCRs 9 , which may reduce expression level of the TCR of interest. In addition, the mispaired TCRs may cause autoimmunity in vivo 11 . Finally, there is only a limited time frame the transduced T-cells can be used. After around one week, the cells undergo apoptosis unless being re-stimulated. However, cells may become exhausted and lose functions with repetitive re-stimulations.
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